Activation of the AT1 receptor causes, among other things, activation of phospholipase C (PLC) and inhibition of adenylyl cyclase (AC) and cAMP/PKA pathway (273), which contribute to hyperinflammation in the course of COVID-19 (274). This evidence concerns the gene AGTR1 and COVID-19.